Teresita P Dejosef, MD | |
111 Lafayette St, Suite 201, Saint Marys, WV 26170-1059 | |
(304) 684-9409 | |
(304) 684-2440 |
Full Name | Teresita P Dejosef |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 111 Lafayette St, Saint Marys, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164410247 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 12410 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Teresita P Dejosef, MD 111 Lafayette St, Suite 201, Saint Marys, WV 26170-1059 Ph: (304) 684-9409 | Teresita P Dejosef, MD 111 Lafayette St, Suite 201, Saint Marys, WV 26170-1059 Ph: (304) 684-9409 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
UV-B radiation in sunlight is the most important factor for the production of vitamin D, and that is why many people suffer from low levels of vitamin D during the winter months.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Children with medulloblastoma, (a type of malignant brain tumour), undergo extensive and debilitating treatment, which has led to marked improvements in survival rates over recent decades. Despite this, these tumours will return in a proportion of patients following treatment (termed relapse), and the vast majority of these will succumb to their disease.
› Verified 6 days ago